Organization

Field Name

ID

Required

KCR

Type of First Recurrence (RecurStatus)

31790

yes

NAACCR

Recurrence Type--1st

1880

yes


Field Length: 2

This item identifies the type of first recurrence after a period of documented disease-free intermission or remission.

Instructions for Coding

  • Code the type of first recurrence.  First recurrence may occur well after completion of the first course of treatment or after subsequent treatment.  

  • If the patient has never been disease-free (code 70), continue to track for disease-free status.  This may occur after subsequent treatment has been completed.

  • If the patient is disease-free (code 00), continue to track until a recurrence occurs.  First recurrence may occur well after completion of the first course of treatment.  

  • Once a recurrence has been recorded (code 04-62 or 88), subsequent recurrences are NOT to be recorded.

  • Codes 00 through 70 are hierarchical.  Record the highest numbered applicable response.

  • If the tumor was originally diagnosed as in situ, code recurrence to 06, 16, 17, 26, 27, 36, or 46 only.  Do not use those codes for any other tumors.  Codes 00, 88, or 99 may apply to any tumor.  

  • Codes 51-59 (organ or organ system of distant recurrence) apply only if all first occurrences were in a single category.  There may be multiple metastases (or "seeding") within the distant location.

  • Code lymphomas or leukemias that are in remission 00.  If the patient relapses, then code recurrence status as 59. If one of these is controlled by drugs (for example Gleevec for CML), the patient is in remission.

  • If there is more than one primary tumor and the physician is unable to decide which has recurred, code the recurrent disease for each tumor.  If, at a later date, the recurrent primary is identified, revise the codes as appropriate.  

Code

Description

00

Patient became disease-free after treatment and has not had a recurrence

04

In situ recurrence of an invasive tumor

06

In situ recurrence of an in-situ tumor

10

Local recurrence, NOS

13

Local recurrence of an invasive tumor

14

Trocar recurrence of an invasive tumor

15

Combination of 13 and 14

16

Local recurrence of an in situ tumor

17

Both local and trocar recurrence of an in situ tumor

20

Regional, NOS

21

Recurrence of an invasive tumor in adjacent tissue or organ(s) only

22

Recurrence of an invasive tumor in regional lymph nodes only

25

Combination of 21 and 22

26

Regional recurrence of an in situ tumor

27

Combination of 26 with 21, 22 and/or 25

30

Any combination of 10-15 and 20-25

36

Any combination of 16-17 and  26-27

40

Distant recurrence, NOS

46

Distant recurrence of an in situ tumor

51

Distant recurrence of an invasive tumor in the peritoneum only. Peritoneum includes peritoneal surfaces of all structures within the abdominal cavity and/or positive ascitic fluid

52

Distant recurrence of an invasive tumor in the lung only. Lung includes the visceral pleura

53

Distant recurrence of an invasive tumor in the pleura only. Pleura includes the pleural surface of all structures within the thoracic cavity and/or positive pleural fluid

54

Distant recurrence of an invasive tumor in the liver only

55

Distant recurrence of an invasive tumor in bone only. This includes bones other than the primary site

56

Distant recurrence of an invasive tumor in the CNS only. This includes the brain and spinal cord, but not the external eye

57

Distant recurrence of an invasive tumor in the skin only. This includes skin other than the primary site

58

Distant recurrence of an invasive tumor in lymph node only. Refer to the staging scheme for a description of lymph nodes that are distant for a particular site

59

Distant systemic recurrence of an invasive tumor only. This includes lymphoma, leukemia, bone marrow metastasis, carcinomatosis, generalized disease

60

Distant recurrence of an invasive tumor in a single distant site (51-58) and local, trocar and/or regional recurrence (10-15, 20-25, or 30)

62

Distant recurrence of an invasive tumor in multiple sites (recurrences that can be coded to more than one category 51-59)

70

Since diagnosis, patient has never been disease-free

88

Recurred, site unknown

99

It is unknown whether the disease has recurred or if the patient was ever disease-free